The global Pet Deworming Drugs market is projected to grow from US$ 323 million in 2024 to US$ 527 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period.
According to the data from the company's "Pet Products Research Center", the global pet industry will reach US$246 billion in 2022, a year-on-year increase of 11.3%. The United States has the highest pet penetration rate and the largest pet consumer market. According to the American Pet Products Association (APPA), 66% of American households own pets, and the total industry sales are about 136.8 billion US dollars, an increase of 10.8% over 2021. . According to IVH, the German pet products industry association, the number of pets in Germany will reach 33.4 million in 2022, with a total turnover of nearly 6.5 billion euros.
Report Covers:
This report presents an overview of global market for Pet Deworming Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pet Deworming Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pet Deworming Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Deworming Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pet Deworming Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pet Deworming Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bimeda Animal Health
Boehringer Ingelheim
Dechra Pharmaceuticals
Droncit
Drontal Plus
Elanco
Merck
Trifexis
Vetoquinol
Zoetis
Segment by Type
Injecting Drugs
Oral Drugs
Others
Segment by Application
Cats
Dogs
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pet Deworming Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pet Deworming Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Deworming Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Pet Deworming Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Pet Deworming Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Injecting Drugs
1.2.3 Oral Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pet Deworming Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cats
1.3.3 Dogs
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pet Deworming Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Pet Deworming Drugs Revenue by Region
2.2.1 Global Pet Deworming Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pet Deworming Drugs Revenue by Region (2019-2024)
2.2.3 Global Pet Deworming Drugs Revenue by Region (2025-2030)
2.2.4 Global Pet Deworming Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Pet Deworming Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Pet Deworming Drugs Sales by Region
2.4.1 Global Pet Deworming Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pet Deworming Drugs Sales by Region (2019-2024)
2.4.3 Global Pet Deworming Drugs Sales by Region (2025-2030)
2.4.4 Global Pet Deworming Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pet Deworming Drugs Sales by Manufacturers
3.1.1 Global Pet Deworming Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Pet Deworming Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet Deworming Drugs in 2023
3.2 Global Pet Deworming Drugs Revenue by Manufacturers
3.2.1 Global Pet Deworming Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Pet Deworming Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pet Deworming Drugs Revenue in 2023
3.3 Global Key Players of Pet Deworming Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pet Deworming Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pet Deworming Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pet Deworming Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pet Deworming Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Pet Deworming Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet Deworming Drugs Sales by Type
4.1.1 Global Pet Deworming Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Pet Deworming Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Pet Deworming Drugs Sales Market Share by Type (2019-2030)
4.2 Global Pet Deworming Drugs Revenue by Type
4.2.1 Global Pet Deworming Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Pet Deworming Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pet Deworming Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Pet Deworming Drugs Price by Type
4.3.1 Global Pet Deworming Drugs Price by Type (2019-2024)
4.3.2 Global Pet Deworming Drugs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pet Deworming Drugs Sales by Application
5.1.1 Global Pet Deworming Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Pet Deworming Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Pet Deworming Drugs Sales Market Share by Application (2019-2030)
5.2 Global Pet Deworming Drugs Revenue by Application
5.2.1 Global Pet Deworming Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Pet Deworming Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pet Deworming Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Pet Deworming Drugs Price by Application
5.3.1 Global Pet Deworming Drugs Price by Application (2019-2024)
5.3.2 Global Pet Deworming Drugs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pet Deworming Drugs Market Size by Type
6.1.1 US & Canada Pet Deworming Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Pet Deworming Drugs Revenue by Type (2019-2030)
6.2 US & Canada Pet Deworming Drugs Market Size by Application
6.2.1 US & Canada Pet Deworming Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Pet Deworming Drugs Revenue by Application (2019-2030)
6.3 US & Canada Pet Deworming Drugs Market Size by Country
6.3.1 US & Canada Pet Deworming Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pet Deworming Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Pet Deworming Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pet Deworming Drugs Market Size by Type
7.1.1 Europe Pet Deworming Drugs Sales by Type (2019-2030)
7.1.2 Europe Pet Deworming Drugs Revenue by Type (2019-2030)
7.2 Europe Pet Deworming Drugs Market Size by Application
7.2.1 Europe Pet Deworming Drugs Sales by Application (2019-2030)
7.2.2 Europe Pet Deworming Drugs Revenue by Application (2019-2030)
7.3 Europe Pet Deworming Drugs Market Size by Country
7.3.1 Europe Pet Deworming Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pet Deworming Drugs Sales by Country (2019-2030)
7.3.3 Europe Pet Deworming Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pet Deworming Drugs Market Size
8.1.1 China Pet Deworming Drugs Sales (2019-2030)
8.1.2 China Pet Deworming Drugs Revenue (2019-2030)
8.2 China Pet Deworming Drugs Market Size by Application
8.2.1 China Pet Deworming Drugs Sales by Application (2019-2030)
8.2.2 China Pet Deworming Drugs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pet Deworming Drugs Market Size by Type
9.1.1 Asia Pet Deworming Drugs Sales by Type (2019-2030)
9.1.2 Asia Pet Deworming Drugs Revenue by Type (2019-2030)
9.2 Asia Pet Deworming Drugs Market Size by Application
9.2.1 Asia Pet Deworming Drugs Sales by Application (2019-2030)
9.2.2 Asia Pet Deworming Drugs Revenue by Application (2019-2030)
9.3 Asia Pet Deworming Drugs Sales by Region
9.3.1 Asia Pet Deworming Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pet Deworming Drugs Revenue by Region (2019-2030)
9.3.3 Asia Pet Deworming Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pet Deworming Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Pet Deworming Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pet Deworming Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pet Deworming Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Pet Deworming Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pet Deworming Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pet Deworming Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Pet Deworming Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pet Deworming Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pet Deworming Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Advantage Multi
11.1.1 Advantage Multi Company Information
11.1.2 Advantage Multi Overview
11.1.3 Advantage Multi Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Advantage Multi Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Advantage Multi Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bayer Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Bimeda Animal Health
11.3.1 Bimeda Animal Health Company Information
11.3.2 Bimeda Animal Health Overview
11.3.3 Bimeda Animal Health Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bimeda Animal Health Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bimeda Animal Health Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Boehringer Ingelheim Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Dechra Pharmaceuticals
11.5.1 Dechra Pharmaceuticals Company Information
11.5.2 Dechra Pharmaceuticals Overview
11.5.3 Dechra Pharmaceuticals Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Dechra Pharmaceuticals Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dechra Pharmaceuticals Recent Developments
11.6 Droncit
11.6.1 Droncit Company Information
11.6.2 Droncit Overview
11.6.3 Droncit Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Droncit Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Droncit Recent Developments
11.7 Drontal Plus
11.7.1 Drontal Plus Company Information
11.7.2 Drontal Plus Overview
11.7.3 Drontal Plus Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Drontal Plus Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Drontal Plus Recent Developments
11.8 Elanco
11.8.1 Elanco Company Information
11.8.2 Elanco Overview
11.8.3 Elanco Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Elanco Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Elanco Recent Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Overview
11.9.3 Merck Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Merck Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Recent Developments
11.10 Trifexis
11.10.1 Trifexis Company Information
11.10.2 Trifexis Overview
11.10.3 Trifexis Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Trifexis Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Trifexis Recent Developments
11.11 Vetoquinol
11.11.1 Vetoquinol Company Information
11.11.2 Vetoquinol Overview
11.11.3 Vetoquinol Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Vetoquinol Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Vetoquinol Recent Developments
11.12 Zoetis
11.12.1 Zoetis Company Information
11.12.2 Zoetis Overview
11.12.3 Zoetis Pet Deworming Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Zoetis Pet Deworming Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zoetis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet Deworming Drugs Industry Chain Analysis
12.2 Pet Deworming Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet Deworming Drugs Production Mode & Process
12.4 Pet Deworming Drugs Sales and Marketing
12.4.1 Pet Deworming Drugs Sales Channels
12.4.2 Pet Deworming Drugs Distributors
12.5 Pet Deworming Drugs Customers
13 Market Dynamics
13.1 Pet Deworming Drugs Industry Trends
13.2 Pet Deworming Drugs Market Drivers
13.3 Pet Deworming Drugs Market Challenges
13.4 Pet Deworming Drugs Market Restraints
14 Key Findings in The Global Pet Deworming Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Advantage Multi
Bayer
Bimeda Animal Health
Boehringer Ingelheim
Dechra Pharmaceuticals
Droncit
Drontal Plus
Elanco
Merck
Trifexis
Vetoquinol
Zoetis
听
听
*If Applicable.